Furthermore, overexpression of Arf GAPs (i.e., AGAP1 and AGAP2) was identified in different cancer types such as breast, colon, lung, ovarian, and hepatocellular carcinoma (57). This evidence concerns the gene CDKN2A and hepatocellular carcinoma.